ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 154751 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 154751; 2) Community: the network communities that were significantly associated with the response to NSC 154751; 3) Molecule: the relationships between components within communities and NSC 154751; 4) MDR: the compounds that were significantly associated with the NSC 154751.

NSC Compound Enrichment Correlation
NSC 683061 Null 0.0401206532535671 0.15671911
NSC 716503 Null 0.0401206532535671 0.20229218
NSC 718564 Null 0.0401206532535671 0.032952754
NSC 718781 Erlotinib hydrochloride 0.0401206532535671 -0.16844237
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0401206532535671 0.29157524
NSC 725098 Null 0.0401206532535671 0.53531169
NSC 729166 N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide 0.0401206532535671 0.10690482
NSC 743532 Null 0.0401206532535671 0.1360467
NSC 748147 5-methyl-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide 0.0401206532535671 0.7724685
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.0401206532535671 0.34650107
Total:146  Current:131    [First] [Prev] [Next] [Last]